BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31283673)

  • 1. Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations.
    Molinari M; Ayloo S; Tsung A; Jorgensen D; Tevar A; Rahman SH; Jonassaint N
    Transplantation; 2019 Oct; 103(10):e297-e307. PubMed ID: 31283673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
    Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living Donor Liver Transplantation in Children: Perioperative Risk Factors and a Nomogram for Prediction of Survival.
    Lu YG; Pan ZY; Zhang S; Lu YF; Zhang W; Wang L; Meng XY; Yu WF
    Transplantation; 2020 Aug; 104(8):1619-1626. PubMed ID: 32732839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid use prior to liver transplant is associated with increased risk of death after transplant.
    Braun HJ; Schwab MP; Jin C; Amara D; Mehta NJ; Grace TR; Croci R; Freise CE; Roberts JP; Hirose R; Ascher NL
    Am J Surg; 2021 Jul; 222(1):234-240. PubMed ID: 33384155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.
    Jackson KR; Motter JD; Haugen CE; Long JJ; King B; Philosophe B; Massie AB; Cameron AM; Garonzik-Wang J; Segev DL
    Transplantation; 2020 Aug; 104(8):1604-1611. PubMed ID: 32732837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
    Brahmbhatt M; Prenner S; Bittermann T
    Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation.
    Ow MM; Erasmus P; Minto G; Struthers R; Joseph M; Smith A; Warshow UM; Cramp ME; Cross TJ
    Liver Transpl; 2014 Sep; 20(9):1081-8. PubMed ID: 24805969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Jackson KR; Bowring MG; Holscher C; Haugen CE; Long JJ; Liyanage L; Massie AB; Ottmann S; Philosophe B; Cameron AM; Segev DL; Garonzik-Wang J
    Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis.
    Conzen KD; Vachharajani N; Collins KM; Anderson CD; Lin Y; Wellen JR; Shenoy S; Lowell JA; Doyle MB; Chapman WC
    HPB (Oxford); 2015 Mar; 17(3):251-7. PubMed ID: 25322849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Trends in Liver Transplant for Metabolic Liver Disease in the United States.
    McKiernan PJ; Ganoza A; Squires JE; Squires RH; Vockley J; Mazariegos G; Soltys K; Sun Q; Sindhi R
    Liver Transpl; 2019 Jun; 25(6):911-921. PubMed ID: 30753750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with mortality within 24h of liver transplantation: An updated analysis of 65,308 adult liver transplant recipients between 2002 and 2013.
    Fukazawa K; Pretto EA; Nishida S; Reyes JD; Gologorsky E
    J Clin Anesth; 2018 Feb; 44():35-40. PubMed ID: 29100021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
    Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.
    Sharma P; Goodrich NP; Schaubel DE; Smith AR; Merion RM
    Liver Transpl; 2017 Sep; 23(9):1143-1152. PubMed ID: 28688150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort.
    Croome KP; Lee DD; Perry DK; Burns JM; Nguyen JH; Keaveny AP; Taner CB
    Liver Transpl; 2017 Mar; 23(3):342-351. PubMed ID: 28027600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.
    Cardoso FS; Karvellas CJ; Kneteman NM; Meeberg G; Fidalgo P; Bagshaw SM
    Can J Gastroenterol Hepatol; 2015 May; 29(4):185-91. PubMed ID: 25965438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.